Ascendis Pharma A/S (NASDAQ:ASND) Receives $202.36 Average PT from Brokerages
Shares of Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) have received an average rating of “Moderate Buy” from the fourteen brokerages that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1-year price […]
Shares of Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) have received an average rating of “Moderate Buy” from the fourteen brokerages that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 1-year price […]
